-
With a growing number of private insurers and agencies such as the Centers for Medicare & Medicaid Services (CMS) heavily involved in pay-for-performance arrangements, quality managers should become proactive about exploring and understanding this growing trend, says one pay-for-performance expert.
-
Make no mistake about it. Hospital CEOs are paying greater attention these days to the growing number of report cards and other publicly available comparable data that show where their facilities stand vis-à-vis the competition.
-
If all hospitals met the quality standards for five high-risk surgeries set by the Washington, DC-based Leapfrog Group, it would save nearly 8,000 lives each year, according to a new study from the University of Michigan (UM) Health System in Ann Arbor.
-
An international group of researchers has created a risk-predicting tool that enables clinicians to calculate the chances that a particular patient will die within six months of going home from the hospital after a heart attack or unstable angina episode. Their work was detailed in an article in the June 9, 2004, issue of the Journal of the American Medical Association.
-
Lakewood, CO-based HealthGrades, whose web site is a leading consumer destination for nationwide quality ratings of hospitals, physicians, and nursing homes, has opened for review its methodology for comparing the nations hospitals in terms of quality. HealthGrades claims 1 million consumers log on to its site each month.
-
This issue reviews the current status of SARS, influenza, and community-acquired pneumonia, providing essential information for emergency physicians and recommendations at a time when the therapeutic landscape for management of patients constantly is evolving.
-
-
-
This paper carried out a clinical study to use gradient-echo MRI to determine prior evidence of microhemorrhages relating to cerebral amyloid angiopathy after patients had presented initially with lobar intracranial hemorrhage.
-
Inflammation in the brain is one of the established features of the neuropathology of Alzheimers Disease (AD). A large case-control study now indicates that patients with elevated serum markers of inflammation have an increased risk of developing AD.
